Bank of New York Mellon’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6M Sell
5,000
-5,000
-50% -$5.11M ﹤0.01% 2333
2026
Q1
$9.2M Hold
10,000
﹤0.01% 1977
2025
Q4
$10.7M Hold
10,000
﹤0.01% 1888
2025
Q3
$7.63M Hold
10,000
﹤0.01% 2083
2025
Q2
$7.8M Hold
10,000
﹤0.01% 2030
2025
Q1
$8.26M Hold
10,000
﹤0.01% 1954
2024
Q4
$7.72M Hold
10,000
﹤0.01% 2058
2024
Q3
$8.86M Buy
+10,000
New +$8.99M ﹤0.01% 1992
2024
Q1
Sell
-4,000
Closed -$2.33M 4249
2023
Q4
$2.33M Hold
4,000
﹤0.01% 2750
2023
Q3
$2.15M Buy
+4,000
New +$2.06M ﹤0.01% 2768
2014
Q1
Sell
-1,500
Closed -$77K 4222
2013
Q4
$77K Buy
+1,500
New +$75.1K ﹤0.01% 4064

Other funds holding LLY

Bank of New York Mellon's LLY Position: Q2 2026 in Review

Bank of New York Mellon reduced its Eli Lilly (LLY) stake by 1.6% in Q2 2026, selling an estimated $78.6M and leaving 4,783,459 shares worth $5.74B. The position accounts for 0.94% of the portfolio, ranked #14.

Bank of New York Mellon first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.96B in Q2 2024. 3,788 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bank of New York Mellon held 4,783,459 shares of Eli Lilly worth $5.74B as of Q2 2026.
  • Bank of New York Mellon sold 76,949 Eli Lilly shares in Q2 2026, an estimated $78.6M.
  • Eli Lilly made up 0.94% of Bank of New York Mellon's portfolio in Q2 2026, its #14 holding.
  • Bank of New York Mellon first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • Bank of New York Mellon's Eli Lilly position peaked at $5.96B in Q2 2024.
  • 3,788 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.